Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Akiharu Ishiyama
Observed names:
A Ishiyama,
A. Ishiyama,
A., Ishiyama,
Akiharu ISHIYAMA,
Ishiyama A,
Ishiyama, A.
show all 6
Institution:
Okazaki City Hospital
Observed institutions:
Konan Kosei Hospital,
Nagoya University Hospital,
Okazaki City Hospital,
Komaki City Hospital,
Tosei General Hospital,
Nagoya University
show all 6
ORCID:
0000-0002-0889-0824
Observed ORCID:
0000-0002-0889-0824
OpenAlex ID:
A5064803578
The Controlling Nutritional Status Score Serves as a Predictor of Short- and Long-Term Outcomes for Patients with Stage 2 or 3 Gastric Cancer: Analysis of a Multi-institutional Data Set
2018
·
Song Ryo
, Mitsuro Kanda
, et al.
·
Annals of Surgical Oncology
·
81
The Preoperative Prognostic Nutritional Index Predicts Short-Term and Long-Term Outcomes of Patients with Stage II/III Gastric Cancer: Analysis of a Multi-Institution Dataset
2019
·
Masahiro Sasahara
, Mitsuro Kanda
, et al.
·
Digestive Surgery
·
64
Multi‐institutional analysis of the prognostic significance of postoperative complications after curative resection for gastric cancer
2019
·
Mitsuro Kanda
, Seiji Ito
, et al.
·
Cancer Medicine
·
52
PDF
Delay in initiation of postoperative adjuvant chemotherapy with S-1 monotherapy and prognosis for gastric cancer patients: analysis of a multi-institutional dataset
2019
·
Koki Nakanishi
, Mitsuro Kanda
, et al.
·
Gastric Cancer
·
49
PDF
Number of retrieved lymph nodes is an independent prognostic factor after total gastrectomy for patients with stage III gastric cancer: propensity score matching analysis of a multi-institution dataset
2018
·
Shogo Hayashi
, Mitsuro Kanda
, et al.
·
Gastric Cancer
·
46
PDF
Intraoperative Blood Loss is Associated with Shortened Postoperative Survival of Patients with Stage II/III Gastric Cancer: Analysis of a Multi‐institutional Dataset
2018
·
Yuki Ito
, Mitsuro Kanda
, et al.
·
World Journal of Surgery
·
46
A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for gastric carcinoma (CCOG0703)
2010
·
Yasuhiro Kodera
, Akiharu Ishiyama
, et al.
·
Gastric Cancer
·
40
PDF
Quality of life and nutritional consequences after aboral pouch reconstruction following total gastrectomy for gastric cancer: randomized controlled trial CCG1101
2015
·
Yuichi Ito
, Takaki Yoshikawa
, et al.
·
Gastric Cancer
·
35
PDF
Propensity-score-matched analysis of a multi-institutional dataset to compare postoperative complications between Billroth I and Roux-en-Y reconstructions after distal gastrectomy
2020
·
Koki Nakanishi
, Mitsuro Kanda
, et al.
·
Gastric Cancer
·
25
PDF
Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer
2019
·
Yasuhito Suenaga
, Mitsuro Kanda
, et al.
·
World Journal of Gastrointestinal Oncology
·
25
PDF
Systemic Inflammation Score as a Predictor of Pneumonia after Radical Resection of Gastric Cancer: Analysis of a Multi-Institutional Dataset
2020
·
Michita Shoka
, Mitsuro Kanda
, et al.
·
Digestive Surgery
·
22
D2 lymph node dissection confers little benefit on the overall survival of older patients with resectable gastric cancer: a propensity score-matching analysis of a multi-institutional dataset
2020
·
Takahiro Shinozuka
, Mitsuro Kanda
, et al.
·
Surgery Today
·
19
Accurate Risk Stratification of Patients with Node‐Positive Gastric Cancer by Lymph Node Ratio
2020
·
Shunsuke Nakamura
, Mitsuro Kanda
, et al.
·
World Journal of Surgery
·
18
Randomized Phase II Trial of CapOX plus Bevacizumab and CapIRI plus Bevacizumab as First-Line Treatment for Japanese Patients with Metastatic Colorectal Cancer (CCOG-1201 Study)
2018
·
Goro Nakayama
, Ayako Mitsuma
, et al.
·
The Oncologist
·
18
PDF
The efficacy and safety of CapeOX plus bevacizumab therapy followed by capecitabine plus bevacizumab maintenance therapy in patients with metastatic colorectal cancer: a multi-center, single-arm, phase II study (CCOG-0902)
2017
·
Goro Nakayama
, Kiyoshi Ishigure
, et al.
·
BMC Cancer
·
16
PDF
Phase II multi-institutional prospective randomized trial comparing S-1 plus paclitaxel with paclitaxel alone as second-line chemotherapy in S-1 pretreated gastric cancer (CCOG0701)
2015
·
Koki Nakanishi
, Daisuke Kobayashi
, et al.
·
International Journal of Clinical Oncology
·
16
Pathological tumor infiltrative pattern and sites of initial recurrence in stage II/III gastric cancer: Propensity score matching analysis of a multi‐institutional dataset
2018
·
Nobuhiko Nakagawa
, Mitsuro Kanda
, et al.
·
Cancer Medicine
·
14
PDF
Association between Lymphovascular Invasion and Recurrence in Patients with pT1N+ or pT2–3N0 Gastric Cancer: a Multi-institutional Dataset Analysis
2020
·
Keizo Fujita
, Mitsuro Kanda
, et al.
·
Journal of the Korean Gastric Cancer Association
·
13
PDF
PTCH gene expression as a potential marker for esophageal squamous cell carcinoma.
2006
·
Akiharu Ishiyama
, Kenji Hibi
, et al.
·
PubMed
·
13
The efficacy and safety of bevacizumab beyond first progression in patients treated with first-line mFOLFOX6 followed by second-line FOLFIRI in advanced colorectal cancer: a multicenter, single-arm, phase II trial (CCOG-0801)
2012
·
Goro Nakayama
, Keisuke Uehara
, et al.
·
Cancer Chemotherapy and Pharmacology
·
12
PDF
Accurate Prediction of Prognosis After Radical Resection of Gastric Cancer by the Modified Systemic Inflammation Score; a Multicenter Dataset Analysis
2021
·
Kota Inagaki
, Mitsuro Kanda
, et al.
·
World Journal of Surgery
·
11
A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for stage III/IV gastric cancer (CCOG 1106)
2014
·
Keisuke Kurimoto
, Kiyoshi Ishigure
, et al.
·
Gastric Cancer
·
11
PDF
Risk score for predicting death from other causes after curative gastrectomy for gastric cancer
2022
·
Yuki Ito
, Takashi Miwa
, et al.
·
Gastric Cancer
·
10
PDF
Survival times are similar among patients with peritoneal, hematogenous, and nodal recurrences after curative resections for gastric cancer
2020
·
Koichi Sawaki
, Mitsuro Kanda
, et al.
·
Cancer Medicine
·
9
PDF
Randomised phase II trial of capecitabine plus oxaliplatin with continuous versus intermittent use of oxaliplatin as adjuvant chemotherapy for stage II/III colon cancer (CCOG-1302 study)
2020
·
Goro Nakayama
, Nao Takano
, et al.
·
European Journal of Cancer
·
8
Show more works
View as search
Works count:
75
Citation count:
765
H-index:
16
I10-index:
23
Year
Topic
Type
